arrow
Back
J

Jonathan L. Kaufman

 emory university

58H-index
575Paper Count
1.7WCitation Count
Published Papers 86
Publication Date
Infection risk in 158 patients with relapsed/refractory multiple myeloma treated with bispecific antibodies: a single-center experience
err2026-02-01
err3
errOAAI
errCani, Lorenzo; Scott, Sara A.; Roberts, Danielle; Joseph, Nisha S.; Hofmeister, Craig C.; Gupta, Vikas A.; V. Dhodapkar, Madhav; Lonial, Sagar; Nooka, Ajay K.; Kaufman, Jonathan L.
errShare
errSave
Preclinical discovery and initial clinical data of WVT078, a BCMA x CD3 bispecific antibody (vol 17, pg 1349, 2023)
errLEUKEMIA
IF13.4
err2025-05-15
err0
PREAI
errRaab, Marc S.; Cohen, Yael C.; Schjesvold, Fredrik; Aardalen, Kimberly; Oka, Adwait; Spencer, Andrew; Wermke, Martin; Souza, Anita D.; Kaufman, Jonathan L.; Cafro, Anna Maria; Ocio, Enrique M.; Doki, Noriko; Henson, Kristin; Trabucco, Gina; Carrion, Ana; Bender, Florent C.; Juif, Pierre-Eric; Fessehatsion, Adonai; Fan, Liqiong; Stonehouse, Jeffrey P.; Blankenship, John W.; Granda, Brian; De Vita, Serena; Lu, Haihui
errShare
errSave
Stem Cell Mobilization Yields with Daratumumab (Dara) and Lenalidomide (Len)-Containing Quadruplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Real-World Experience at 2 Institutes
err2025-04-11
err0
PREAI
errCindy Varga; Myra Robinson; Vikas Gupta; Craig C. Hofmeister; Ajay K. Nooka; Jonathan L. Kaufman; Madhav V. Dhodapkar; Sagar Lonial; Shanice Borden; Christopher Ferreri; Barry Paul; Shebli Atrash; Manisha Bhutani; Peter M. Voorhees; Nisha S. Joseph
errShare
errSave
Daratumumab for newly diagnosed multiple myeloma: Pooled analysis of patients aged ≥65 years from GRIFFIN and PERSEUS
err2025-04-11
err0
PREAI
errPaula Rodriguez-Otero; Peter M. Voorhees; Mario Boccadoro; Jacob Laubach; Hermann Einsele; Douglas W. Sborov; Meletios A. Dimopoulos; Annemiek Broijl; Roberto Mina; Andrew Spencer; Fredrik Schjesvold; Rebecca Silbermann; Francesca Gay; Luciano J. Costa; Aurore Perrot; Yanfang Liu; Jianping Wang; Anna Sitthi-Amorn; Robin Carson; Annelore Cortoos; Saad Z. Usmani; Paul G. Richardson; Philippe Moreau; Pieter Sonneveld; Jonathan L. Kaufman
errShare
errSave
Feasibility and Safety of Outpatient Model for Administration of Bispecific Antibodies: Proceedings from an International Myeloma Society 21st Annual Meeting Oral Abstract
err2025-04-08
err0
errOAAI
errSara A Scott; Danielle L. Roberts; Vikas A. Gupta; Nisha S. Joseph; Craig C. Hofmeister; Madhav V. Dhodapkar; Sagar Lonial; Ajay K. Nooka; Jonathan L. Kaufman
errShare
errSave
BCL2 inhibition for multiple myeloma and AL amyloidosis
err2025-03-16
err0
PREAI
errCani, Lorenzo; Gupta, Vikas A.; Kaufman, Jonathan L.
errShare
errSave
Comment on Sidana et al, page 85 Solvitur ambulando
errBLOOD
IF23.1
err2025-01-02
err0
PREAI
errKaufman, Jonathan L.
errShare
errSave
Stem Cell Mobilization Yields with Daratumumab (Dara) and Lenalidomide (Len)-Containing Quadruplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Real-World Experience at Two Institutes
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errVarga, Cindy; Robinson, Myra; Gupta, Vikas; Hofmeister, Craig C.; Nooka, Ajay K.; Kaufman, Jonathan L.; Dhodapkar, Madhav, V; Lonial, Sagar; Borden, Shanice; Ferreri, Christopher; Paul, Barry; Atrash, Shebli; Bhutani, Manisha; Voorhees, Peter M.; Joseph, Nisha S.
errShare
errSave
Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity
err2024-10-27
err1
errOAAI
errMoreno, Alberto; Manning, Kelly; Azeem, Maryam I.; Nooka, Ajay K.; Ellis, Madison; Manalo, Renee Julia; Switchenko, Jeffrey M.; Wali, Bushra; Kaufman, Jonathan L.; Hofmeister, Craig C.; Joseph, Nisha S.; Lonial, Sagar; Dhodapkar, Kavita M.; Dhodapkar, Madhav V.; Suthar, Mehul S.
errShare
errSave
A plain language summary of the final analysis of the GRIFFIN study of daratumumab plus lenalidomide, bortezomib, and dexamethasone for people with newly diagnosed multiple myeloma
err2024-10-25
err0
errOAAI
errVoorhees, Peter M.; Sborov, Douglas W.; Laubach, Jacob; Kaufman, Jonathan L.; Reeves, Brandi; Rodriguez, Cesar; Silbermann, Rebecca; Costa, Luciano J.; Anderson, Larry D.; Nathwani, Nitya; Shah, Nina; Bumma, Naresh; Efebera, Yvonne A.; Holstein, Sarah A.; Costello, Caitlin; Jakubowiak, Andrzej; Wildes, Tanya M.; Orlowski, Robert Z.; Shain, Kenneth H.; Cowan, Andrew J.; Dinner, Shira; Gries, Katharine S.; Pei, Huiling; Cortoos, Annelore; Patel, Sharmila; Lin, Thomas S.; Usmani, Saad Z.; Richardson, Paul G.
errShare
errSave
Quadruplet therapy for newly diagnosed myeloma: comparative analysis of sequential cohorts with triplet therapy lenalidomide, bortezomib and dexamethasone (RVd) versus daratumamab with RVD (DRVd) in transplant-eligible patients
err2024-09-13
err0
errOAAI
errJoseph, Nisha S.; Kaufman, Jonathan L.; Gupta, Vilas A.; Hofmeister, Craig C.; Dhodapkar, Madhav V.; Boise, Lawrence H.; DiCamillo, Sara M.; Roberts, Danielle; Nooka, Ajay K.; Lonial, Sagar
errShare
errSave
Clinical response and pathway-specific correlates following TIGIT-LAG3 blockade in myeloma: the MyCheckpoint randomized clinical trial
err2024-08-26
err2
PREAI
errRichard, Shambavi; Lesokhin, Alexander M.; Paul, Barry; Kaufman, Jonathan L.; Pianko, Matthew; Biran, Noa; Vij, Ravi; Doxie, Deon B.; Azeem, Maryam I.; Martillo, Mercedes; Wozniak, Katie; Cho, Hearn J.; Dhodapkar, Kavita M.; Dhodapkar, Madhav V.
errShare
errSave
Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN
err2024-07-08
err0
errOAAI
errChari, Ajai; Kaufman, Jonathan L.; Laubach, Jacob; Sborov, Douglas W.; Reeves, Brandi; Rodriguez, Cesar; Silbermann, Rebecca; Costa, Luciano J.; Anderson Jr, Larry D.; Nathwani, Nitya; Shah, Nina; Bumma, Naresh; Holstein, Sarah A.; Costello, Caitlin; Jakubowiak, Andrzej; Wildes, Tanya M.; Orlowski, Robert Z.; Shain, Kenneth H.; Cowan, Andrew J.; Pei, Huiling; Cortoos, Annelore; Patel, Sharmila; Lin, Thomas S.; Voorhees, Peter M.; Usmani, Saad Z.; Richardson, Paul G.
errShare
errSave
Pembrolizumab and low-dose, single-fraction radiotherapy for patients with relapsed or refractory multiple myeloma: a prospective, single-centre, single-group, open-label, phase 2 pilot trial in the USA
err2024-07-01
err2
PREAI
errKhan, Mohammad K.; Nasti, Tahseen H.; Qian, Joshua Y.; Kleber, Troy J.; Switchenko, Jeffrey M.; Kaufman, Jonathan L.; Nooka, Ajay J.; Dhodapkar, Madhav, V; Buchwald, Zachary S.; Obiekwe, Daby; Lonial, Sagar; Ahmed, Rafi
errShare
errSave
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials
errCANCER
IF5.1
err2024-06-28
err0
PREAI
errMetts, Jonathan L.; Aye, Jamie M.; Crane, Jacquelyn N.; Oberoi, Sapna; Balis, Frank M.; Bhatia, Smita; Bona, Kira; Carleton, Bruce; Dasgupta, Roshni; Dela Cruz, Filemon S.; Greenzang, Katie A.; Kaufman, Jonathan L.; Linardic, Corinne M.; Parsons, Susan K.; Robertson-Tessi, Mark; Rudzinski, Erin R.; Soragni, Alice; Stewart, Elizabeth; Weigel, Brenda J.; Wolden, Suzanne L.; Weiss, Aaron R.; Venkatramani, Rajkumar; Heske, Christine M.
errShare
errSave
Transposon DNA sequences facilitate the tissue-specific gene transfer of circulating tumor DNA between human cells
err2024-05-23
err1
errOAAI
errCinar, Munevver; Martinez-Medina, Lourdes; Puvvula, Pavan K.; Arakelyan, Arsen; Vardarajan, Badri N.; Anthony, Neil; Nagaraju, Ganji P.; Park, Dongkyoo; Feng, Lei; Sheff, Faith; Mosunjac, Marina; Saxe, Debra; Flygare, Steven; Alese, Olatunji B.; Kaufman, Jonathan L.; Lonial, Sagar; Sarmiento, Juan M.; Lossos, Izidore S.; Vertino, Paula M.; Lopez, Jose A.; El-Rayes, Bassel; Bernal-Mizrachi, Leon
errShare
errSave
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk
err2024-04-22
err7
errOAAI
errCallander, Natalie S.; Silbermann, Rebecca; Kaufman, Jonathan L.; Godby, Kelly N.; Laubach, Jacob; Schmidt, Timothy M.; Sborov, Douglas W.; Medvedova, Eva; Reeves, Brandi; Dhakal, Binod; Rodriguez, Cesar; Chhabra, Saurabh; Chari, Ajai; Bal, Susan; Anderson, Larry D.; Dholaria, Bhagirathbhai R.; Nathwani, Nitya; Hari, Parameswaran; Shah, Nina; Bumma, Naresh; Holstein, Sarah A.; Costello, Caitlin; Jakubowiak, Andrzej; Wildes, Tanya M.; Orlowski, Robert Z.; Shain, Kenneth H.; Cowan, Andrew J.; Pei, Huiling; Cortoos, Annelore; Patel, Sharmila; Lin, Thomas S.; Giri, Smith; Costa, Luciano J.; Usmani, Saad Z.; Richardson, Paul G.; Voorhees, Peter M.
errShare
errSave
Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone: Patient-reported outcomes from GRIFFIN
err2024-04-15
err0
errOAAI
errSilbermann, Rebecca; Laubach, Jacob; Kaufman, Jonathan L.; Sborov, Douglas W.; Reeves, Brandi; Rodriguez, Cesar; Chari, Ajai; Costa, Luciano J.; Anderson, Larry D.; Nathwani, Nitya; Shah, Nina; Bumma, Naresh; Holstein, Sarah A.; Costello, Caitlin; Jakubowiak, Andrzej; Orlowski, Robert Z.; Shain, Kenneth H.; Cowan, Andrew J.; Gries, Katharine S.; Pei, Huiling; Cortoos, Annelore; Patel, Sharmila; Lin, Thomas S.; Voorhees, Peter M.; Usmani, Saad Z.; Richardson, Paul G.
errShare
errSave
The anti-BCMA antibody-drug conjugate HDP-101 with a novel amanitin payload shows promising initial first in human results in relapsed multiple myeloma
err2024-04-05
err1
PREAI
errKaufman, Jonathan; Raab, Marc; Richard, Shambavi; Grosicki, Sebastian; Takacs, Istvan; Strassz, Andras; Pahl, Andreas; Kulke, Michael; Michael, Thorsten; Last, Anette; Szaboki, Hajnalka; Jentsch, Garrit; Schonborn-Kellenberger, Oliver; Orlowski, Robert
errShare
errSave
Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience
err2023-12-20
err9
errOAAI
errScott, Sara A.; Marin, Ellen M.; Maples, Kathryn T.; Joseph, Nisha S.; Hofmeister, Craig C.; Gupta, Vikas A.; Dhodapkar, Madhav V.; Kaufman, Jonathan L.; Lonial, Sagar; Nooka, Ajay K.
errShare
errSave